Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01458951
Other study ID # A3921095
Secondary ID 2011-004579-35OC
Status Completed
Phase Phase 3
First received October 21, 2011
Last updated August 20, 2015
Start date June 2012
Est. completion date June 2015

Study information

Verified date August 2015
Source Pfizer
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

This study is designed to evaluate the efficacy and safety of tofacitinib (CP-690,550) in patients with moderate to severe ulcerative colitis who have failed or be intolerant to one of following treatments for ulcerative colitis: oral steroids, azathiopurine/6-mercaptopurine, or anti-TNF-alpha therapy.


Recruitment information / eligibility

Status Completed
Enrollment 547
Est. completion date June 2015
Est. primary completion date May 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Subject must be at least 18 years of age.

- Males and females with a documented diagnosis of UC at least 4 months prior to entry into the study.

- Subjects with moderately to severely active UC based on Mayo score criteria.

- Subjects must have failed or be intolerant of at least one of the following treatments for UC:

- Corticosteroids (oral or intravenous).

- Azathioprine or 6 mercaptopurine (6 MP).

- Anti TNF therapy.

Exclusion Criteria:

- Presence of indeterminate colitis, microscopic colitis, ischemic colitis, infectious colitis, or clinical findings suggestive of Crohn's disease.

- Subjects with disease limited to distal 15 cm.

- Subjects without previous treatment for UC (ie, treatment naïve).

- Subjects displaying clinical signs of fulminant colitis or toxic megacolon.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
tofacitinib
10 mg oral BID
Placebo
Placebo oral BID

Locations

Country Name City State
Australia Monash Medical Centre Clayton Victoria
Australia Concord Repatriation General Hospital Concord New South Wales
Australia The Canberra Hospital Garran Australian Capital Territory
Australia Liverpool Hospital Eastern Campus Liverpool New South Wales
Austria Medizinische Universitat Innsbruck Innsbruck
Austria Krankenhaus Barmherzige Brueder St. Veit/Glan St. Veit an der Glan
Belgium GZA St Vincentius Antwerpen
Belgium AZ Groeninge, Campus Kennedylaan Kortrijk
Belgium H-Hartziekenhuis Roeselare-Menen vzw Roeselare
Brazil Hospital de Clinicas de Porto Alegre - HCPA Porto Alegre Rio Grande do Sul
Canada University of Alberta - Zeidler Ledcor Centre Edmonton Alberta
Canada University of Alberta Hospital - Walter C. Mackenzie Health Sciences Centre Edmonton Alberta
Canada Montreal General Hospital - McGill University Health Centre Montreal Quebec
Canada Royal University Hospital Saskatoon Saskatchewan
Canada Saskatoon City Hospital Saskatoon Saskatchewan
Colombia Instituto de Coloproctologia ICO S.A.S. Medellin Antioquia
Croatia University Hospital Center Osijek, Clinic of Internal Medicine, Osijek
Croatia University Hospital Rijeka Rijeka
Croatia University Hospital Center Zagreb,Department of Gastroenterology Zagreb
Czech Republic Nemocnice Strakonice, a.s., Interni oddeleni Strakonice
Czech Republic Krajska Zdravotni a.s., Masarykova nemocnice Usti nad Labem, o.z. Usti nad Labem
Denmark Bispebjerg Hospital Copenhagen NV
Denmark Hvidovre Hospital Hvidovre
Denmark Odense University Hospital Syddanmark
Estonia Mammograaf OU (Endoscopy Only) Talinn
Estonia East Tallinn Central Hospital Internal Medicine Clinic Tallinn
Estonia ECG Unit, East Tallinn Central Hospital Tallinn
Estonia ECG Unit, Innomedica OU and Qualitas AS (ECG Only) Tallinn
Estonia Innomedica OU Tallinn
Estonia Quattromed HTI Laboratorid OU Tallinn
Estonia X-Ray Unit, East Tallinn Central Hospital Tallinn
Estonia X-Ray Unit, Qualitas AS (X-Ray Only) Tallinn
France CHU Amiens PICARDIE - Hopital SUD Amiens Cedex 1
France Hopital Saint Andre Bordeaux cedex
France Hopital Beaujon Clichy Cedex
France Hopital Saint Antoine Paris Cedex 12
France C.H.U. de Reims - Hôpital Robert Debré Reims cedex
France CHU de Reims - Pharmacie Reims Cedex
France Hopital Nord St Priest En Jarez
Germany Klinikum der Johann Wolfgang Goethe-Universitaet Frankfurt
Germany Universitäetsklinik Schleswig-Holstein, Campus Kiel Kiel Schlewig Holstein
Germany Gastroenterologische Gemeinschaftspraxis Minden Minden
Germany University Hospital Munich-Grosshadern Munich
Germany Universitaetsklinikum Ulm Ulm
Hungary Dr. Rethy Pal Korhaz-Rendelointezet- III. Belgyogyaszat Bekescsaba
Hungary MH Honvedkorhaz Budapest
Hungary Pannonia Maganorvosi Centrum Kft. Budapest
Hungary Peterfy Sandor utcai Korhaz- Rendelointezet es Baleseti Kozpontl. Belgyogyaszat Budapest
Hungary Szent Janos Korhaz és Eszak-budai Egyesített Korhazak Budapest
Hungary Debreceni Egyetem Klinikai Központ Belgyógyászati Intézet, Gasztroenterológiai Tanszék Debrecen
Hungary Bekes Megyei Pandy Kalman Korhaz Gyula
Hungary Borsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktató Kórház Miskolc
Hungary Karolina Korhaz Rendelointezet, Belgyogyaszat Mosonmagyarovar
Israel Auckland City Hospital Auckland
Israel The Edith Wolfson Medical Center/Gastroenterology Institute Holon
Israel Kaplan Medical Center Rehovot
Korea, Republic of Pusan National University Hospital Busan
Korea, Republic of Kyung Hee University Hospital, Clinical Laboratory Dongdaemun-gu Seoul
Korea, Republic of Hanyang University Guri Hospital, Clinical Laboratory Guri-si Gyunggi-do
Korea, Republic of Gachon University Gil Hospital Incheon
Korea, Republic of Pusan National University Hospital, Clinical Laboratory Seo-Gu Busan
Korea, Republic of CHA Bundang Medical Center, CHA University Seongnam-si Gyeonggi-do
Korea, Republic of Asan Medical Center Seoul
Korea, Republic of Asan Medical Center, Clinical Laboratory Seoul
Korea, Republic of Samsung Medical Center Seoul
Korea, Republic of Seoul National University Hospital Seoul
Korea, Republic of Severance Hospital, Yonsei University Health System Seoul
Latvia Daugavpils Regional Hospital Daugavpils
Latvia Daugavpils Regional Hospital Microbiology and Clinical Laboratory Daugavpils
Netherlands Academic Medical Centre (AMC), Amsterdam
Netherlands VU University Medical Center (VUMC) Amsterdam
Netherlands University Medical Center Groningen (UMCG) Groningen
New Zealand Auckland City Hospital Auckland
New Zealand Christchurch Hospital Christchurch Canterbury
New Zealand Waikato Hospital Hamilton
New Zealand Bowen Hospital Wellington
New Zealand P3 Research Limited Wellington
New Zealand Pacific Radiology (X-rays only) Wellington
Poland Oddzial Chorob Wewnetrznych i Gastroenterologii, Bialystok
Poland Centrum Endoskopii Zabiegowej Bydgoszcz Kujawsko-Pomorskie
Poland Gabinet Endoskopii Przewodu Pokarmowego Krakow
Poland Centrum Medyczne Szpital Sw. Rodziny Sp. z o.o. Lodz
Poland Endoskopia SP. Z O.O. Sopot
Poland H-T. Centrum Medyczne - ENDOTERAPIA Tychy Slaskie
Poland Nzoz Vivamed Warszawa
Romania Spitalul Universitar de Urgenta Bucuresti, Sectia De Medicina Intema II si Gastroenterologie Bucuresti Sector 5
Romania Spitalul Clinic Judetean Mures, Sectia Clinica de Gastroenterologie Targu Mures Mures
Russian Federation Federal state budget institution "State scientific centre of coloproctology" Moscow
Russian Federation State budget Healthcare Institution Moscow regional scientific research clinical institute Moscow
Russian Federation State budget institution of healthcare "City Clinical Hospital # 51 healthcare department of Moscow" Moscow Russia
Russian Federation FGBU "Scientific Research Institute of Physiology and Fundamental Medicine"Siberian Branch of RAMS Novosibirsk
Russian Federation Municipal institution of healthcare "City clinical hospital 12" Saratov
Russian Federation Municipal institution of healthcare "Clinical Hospital # 2" Yaroslavl Russia
Russian Federation OOO Medical Center of Diagnostics and Prophylaxis "Sodruzhestvo" Yaroslavl Russia
Russian Federation State Institution of healthcare Yaroslavl Regional Clinical Hospital Yaroslavl
Serbia Clinical Centre of Serbia, Clinic for Gastroenterology and Hepatology Belgrade
Serbia Clinical Centre of Vojvodina, Clinic for Gastroenterology and Hepatology Novi Sad
Serbia Clinical Centre of Vojvodina, Emergency Internal Medicine Division Novi Sad
Serbia General Hospital Subotica Subotica
Slovakia Lama Medical Care s.r.o. Bratislava
Slovakia KM Management spol. s r.o. Nitra
Slovakia Poliklinika Libris, Synergy group, a.s. Nove Mesto Nad Vahom
Slovakia Gastro I., s.r.o. Presov
South Africa Panorama Medi-Clinic Cape Town Western Cape
South Africa The Louis Leipoldt Medical Centre Cape Town Western Cape
South Africa Dr JP Wright Claremont, Cape Town Western Cape
Spain Hospital Universitario de Bellvitge Barcelona
Spain Corporacio Sanitaria Parc Tauli Sabadell Barcelona
Taiwan Chung Shan Medical University Hospital Taichung
Taiwan National Taiwan University Hospital Taipei City
Ukraine Local laboratory of Regional Municipal Institution ¿Chernivtsi Regional Clinical Hospital¿ Chernivtsi
Ukraine Regional Municipal Institution Chernivtsi Regional Clinical Hospital Chernivtsi
Ukraine Regional Municipal Institution "Chernivtsi Regional Clinical Hospital" Chernivtsi,
Ukraine State Institution Institute of Gastroenterology of the National Academy of Medical Sciences of Ukra Dniepropetrovsk
Ukraine Municipal Healthcare Institution ¿Kharkiv City Clinical Hospital #2¿, Proctology Department Kharkiv
Ukraine Kyiv City Clinical Hospital #8, Kiev
Ukraine Department of clinical and laboratory diagnostic of Municipal Institution Odesa
Ukraine Municipal Institution "Odesa Regional Clinical Hospital" Odesa
Ukraine Medical Clinical Research Center "Health Clinic" on the base of Vynnytsya
Ukraine Minicipal Institution 'City Hospital Zaporizhzhia
United Kingdom University Hospitals Bristol NHS Foundation Trust Bristol
United Kingdom St Mark's Hospital Harrow Middlesex
United Kingdom Norfolk and Norwich University Hospital Norwich Norfolk
United States Texas Clinical Research Institiute Arlington Texas
United States Austin Gastroenterology PA Austin Texas
United States Austin Gastroenterology PA/Professional Quality Research, Inc. Austin Texas
United States Bristol Hospital Bristol Connecticut
United States Connecticut Clinical Research Foundation Bristol Connecticut
United States Clinical Research Institute of Michigan, LLC Chesterfield Michigan
United States Chevy Chase Endoscopy Center (Endoscopies only) Chevy Chase Maryland
United States Metropolitan Gastroenterology Group, PC - Chevy Chase Clinical Research Chevy Chase Maryland
United States Surgery Center of Columbia Columbia Missouri
United States Citrus Surgery & Endoscopy Center (Colonoscopy) Crystal River Florida
United States Atlanta Center for Gastroenterology, P.C. Decatur Georgia
United States AGA Clinical Research Associates, LLC Egg Harbor Township New Jersey
United States Carolina Research - Carolina Digestive Diseases Greenville North Carolina
United States Hannibal Regional Hospital Hannibal Missouri
United States Memorial Hermann Hospital Houston Texas
United States The University of Texas Health Science Center at Houston Houston Texas
United States Nature Coast Clinical Research Inverness Florida
United States Suncoast Endoscopy Center (colonoscopy) Inverness Florida
United States Regional Gastroenterology Associates of Lancaster, Ltd. Lancaster Pennsylvania
United States Dartmouth-Hitchcock Medical Center Lebanon New Hampshire
United States South Jersey Gastroenterology Marlton New Jersey
United States Audrain Medical Center Mexico Missouri
United States Center for Digestive & Liver Disease, Inc. Mexico Missouri
United States Gastroenterology Group of Naples Naples Florida
United States Vanderbilt University Medical Center - Drug Shipment Nashville Tennessee
United States Vanderbilt University Medical Center - GCRC Nashville Tennessee
United States Vanderbilt University Medical Center - GI Research Office Nashville Tennessee
United States Vanderbilt University Medical Center - Heart Station Nashville Tennessee
United States Vanderbilt University Medical Center - IBD Clinic Nashville Tennessee
United States Vanderbilt University Medical Center - Radiology Nashville Tennessee
United States Yale New Haven Hospital New Haven Connecticut
United States Yale University School of Medicine New Haven Connecticut
United States Alliance Clinical Research Oceanside California
United States Central Connecticut Endoscopy Center Plainville Connecticut
United States Advanced Gastroenterology Center Port Orange Florida
United States Advanced Medical Research Center Port Orange Florida
United States Endoscopy Center Port Orange Florida
United States Port Orange Urgent Care Port Orange Florida
United States VCU Health System Digestive Health Center Richmond Virginia
United States VCU Health System Endoscopy Suite Richmond Virginia
United States VCU Medical Center Investigational Drug Service (IDS) Richmond Virginia
United States Virginia Commonwealth University Richmond Virginia
United States Mayo Clinic Rochester Minnesota
United States University of Rochester Rochester New York
United States Clinical Application Laboratories San Diego California
United States San Diego Endoscopy Center San Diego California
United States Medical Center at Mount Zion San Francisco California
United States UCSF Endoscopy Unit at Mount Zion San Francisco California
United States University of California San Francisco San Francisco California
United States Gastrointestinal Specialists, A.M.C. Shreveport Louisiana
United States Louisiana Research Center, LLC Shreveport Louisiana
United States Shreveport Endoscopy Center, A.M.C. Shreveport Louisiana
United States Cotton-O'Neil Clinical Research Center, Digestive Health Topeka Kansas
United States Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Torrance California
United States Center for Digestive Health Troy Michigan
United States Surgical Centers of Michigan Troy Michigan
United States Desert Sun Clinical Research, LCC Tucson Arizona
United States Desert Sun Gastroenterology Tucson Arizona
United States Desert Sun Surgery Center Tucson Arizona
United States Digestive Health Specialists of Tyler Tyler Texas
United States The Gastroenterology Group of South Jersey Vineland New Jersey
United States The Endo Center at Voorhees Voorhees New Jersey

Sponsors (1)

Lead Sponsor Collaborator
Pfizer

Countries where clinical trial is conducted

United States,  Australia,  Austria,  Belgium,  Brazil,  Canada,  Colombia,  Croatia,  Czech Republic,  Denmark,  Estonia,  France,  Germany,  Hungary,  Israel,  Korea, Republic of,  Latvia,  Netherlands,  New Zealand,  Poland,  Romania,  Russian Federation,  Serbia,  Slovakia,  South Africa,  Spain,  Taiwan,  Ukraine,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary The proportion of subjects in remission at Week 8. 8 weeks No
Secondary The proportion of subjects achieving mucosal healing at Week 8. 8 weeks No
Secondary The proportion of subjects achieving clinical response at Week 8. 8 weeks No
Secondary The proportion of subjects in clinical remission at Week 8. 8 weeks No
Secondary The proportion of subjects in symptomatic remission at Week 8. 8 weeks No
Secondary The proportion of subjects achieving deep remission at Week 8. 8 weeks No
Secondary Partial Mayo scores and change from baseline over time. 8 weeks No
Secondary Change from baseline at Week 8 in total Mayo score. 8 weeks No
See also
  Status Clinical Trial Phase
Recruiting NCT05702879 - Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success
Not yet recruiting NCT05953402 - A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
Recruiting NCT05316584 - A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy N/A
Recruiting NCT03950232 - An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis Phase 3
Completed NCT03124121 - Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels Phase 4
Not yet recruiting NCT06100289 - A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease Phase 3
Withdrawn NCT04209556 - A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis Phase 2
Terminated NCT00061282 - Clotrimazole Enemas for Pouchitis in Children and Adults Phase 1/Phase 2
Recruiting NCT04398550 - SCD vs. Mediterranean Diet Therapy in Ulcerative Colitis N/A
Recruiting NCT04314375 - Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis Phase 4
Active, not recruiting NCT04857112 - Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis Phase 2
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Active, not recruiting NCT04033445 - A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis Phase 2/Phase 3
Recruiting NCT05428345 - A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Active, not recruiting NCT06221995 - Energy Expenditure in Patients With Ulcerative Colitis Undergoing Surgery
Recruiting NCT04767984 - Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis Phase 2
Completed NCT02508012 - Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases N/A
Recruiting NCT06071312 - FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach Phase 1/Phase 2
Completed NCT03760003 - Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis Phase 2
Not yet recruiting NCT05539625 - Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis Phase 2